Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillator Therapy in Patients With Tetralogy of Fallot.

Saved in:
Bibliographic Details
Title: Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillator Therapy in Patients With Tetralogy of Fallot.
Authors: Waldmann V, Marquié C, Bouzeman A, Duthoit G, Thambo JB, Koutbi L, Maltret A, Pasquié JL, Combes N, Marijon E
Source: Journal of the American College of Cardiology [J Am Coll Cardiol] 2022 Oct 25; Vol. 80 (17), pp. 1701-1703.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-3597
DOI:10.1016/j.jacc.2022.08.761